Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts
US-11918638-B2 · Mar 5, 2024 · US
Inactivation or attenuation; Producing viral sub-units
Inactivation or attenuation; Producing viral sub-units · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C12N7/04 |
| Official title | Inactivation or attenuation; Producing viral sub-units |
| Display label | Inactivation or attenuation; Producing viral sub-units |
| Total patents | 155 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 9 |
| 2016 | 15 |
| 2017 | 17 |
| 2018 | 19 |
| 2019 | 22 |
| 2020 | 19 |
| 2021 | 16 |
| 2022 | 10 |
| 2023 | 8 |
| 2024 | 9 |
| 2025 | 7 |
| 2026 | 4 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Feline calicivirus vaccine
US-2018371026-A1 · Dec 27, 2018 · US
Viable viruses with foreign tags
US-2018344837-A1 · Dec 6, 2018 · US
Method for preparing a vaccine antigen, resulting vaccine antigen and uses
US-10144917-B2 · Dec 4, 2018 · US
Inactivated varicella zoster virus vaccines, methods of production, and uses thereof
US-2018318412-A1 · Nov 8, 2018 · US
Attenuated virus mutated at sites of evolutionarily conserved rna structure
US-2018273911-A1 · Sep 27, 2018 · US
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling mutations in leukocytes
US-2018255751-A1 · Sep 13, 2018 · US
Fcv recombinant vaccines and uses thereof
US-2018243399-A1 · Aug 30, 2018 · US
Method for rapid generation of an attenuated rna virus
US-2018201908-A1 · Jul 19, 2018 · US
Modified CPMV Enhancer Elements
US-2018119158-A1 · May 3, 2018 · US
Viral gene therapy as treatment for cholesterol storage disease or disorder
US-2018104289-A1 · Apr 19, 2018 · US
Recombinant isfahan viral vectors
US-9932564-B2 · Apr 3, 2018 · US
Constructs for continuous monitoring of live cells
US-2018079786-A1 · Mar 22, 2018 · US
Immunization with rabies virus vector expressing foreign protein antigen
US-9889192-B2 · Feb 13, 2018 · US
Attenuated influenza vaccines and uses thereof
US-9878032-B2 · Jan 30, 2018 · US
Rotavirus-like particle production in plants
US-2018016561-A1 · Jan 18, 2018 · US
Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
US-2018008693-A1 · Jan 11, 2018 · US
Influenza virus vaccination regimens
US-2018008696-A1 · Jan 11, 2018 · US
Method for in-vitro preparation of double-layered virus-like particles of rotavirus
US-9862933-B2 · Jan 9, 2018 · US
Method for preparing a vaccine antigen, resulting vaccine antigen and uses
US-2017362578-A1 · Dec 21, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C12N7/04?
- CPC C12N7/04 is the Cooperative Patent Classification code for “Inactivation or attenuation; Producing viral sub-units.”
- How many patents are filed under CPC C12N7/04 (Inactivation or attenuation; Producing viral sub-units)?
- Our database includes 155 publications tagged with this CPC code.
- Is patent activity under CPC C12N7/04 growing?
- Publication counts under this code: 9 in 2024 vs 7 in 2025 (latest complete years).